Funding for this research was provided by:
Foundation for the National Institutes of Health
Received: 13 March 2019
Accepted: 8 April 2020
First Online: 12 May 2020
: S.B. consults with and/or receives research funding from Pfizer, Ideaya Biosciences and Revolution Medicines. F.M. consults with Pfizer, Amgen, BridgeBio, Ideaya Biosciences, Quanta, Aduro, Wellspring and Leidos. A.B. is on the SAB of Mission Bio and receives research funding from Bristol Meyers Squibb. The remaining authors declare no competing interests.